Next Article in Journal
Recent Advances in Understanding the Control of Secretory Proteins by the Unfolded Protein Response in Plants
Next Article in Special Issue
Melatonin Effects on Hard Tissues: Bone and Tooth
Previous Article in Journal
Simple and Rapid Synthesis of Magnetite/Hydroxyapatite Composites for Hyperthermia Treatments via a Mechanochemical Route
Previous Article in Special Issue
Role of Melatonin in Schizophrenia
Int. J. Mol. Sci. 2013, 14(5), 9379-9395; doi:10.3390/ijms14059379
Review

Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia

* ,
,
,
 and
Received: 28 February 2013 / Revised: 15 April 2013 / Accepted: 16 April 2013 / Published: 29 April 2013
(This article belongs to the Special Issue Advances in the Research of Melatonin)
View Full-Text   |   Download PDF [2530 KB, uploaded 19 June 2014]   |   Browse Figure

Abstract

One of the most common causes of mortality and morbidity in children is perinatal hypoxia-ischemia (HI). In spite of the advances in neonatology, its incidence is not diminishing, generating a pediatric population that will require an extended amount of chronic care throughout their lifetime. For this reason, new and more effective neuroprotective strategies are urgently required, in order to minimize as much as possible the neurological consequences of this encephalopathy. In this sense, interest has grown in the neuroprotective possibilities of melatonin, as this hormone may help to maintain cell survival through the modulation of a wide range of physiological functions. Although some of the mechanisms by which melatonin is neuroprotective after neonatal asphyxia remain a subject of investigation, this review tries to summarize some of the most recent advances related with its use as a therapeutic drug against perinatal hypoxic-ischemic brain injury, supporting the high interest in this indoleamine as a future feasible strategy for cerebral asphyctic events.
Keywords: melatonin; neuroprotection; hypoxia-ischemia; newborn melatonin; neuroprotection; hypoxia-ischemia; newborn
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Alonso-Alconada, D.; Álvarez, A.; Arteaga, O.; Martínez-Ibargüen, A.; Hilario, E. Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia. Int. J. Mol. Sci. 2013, 14, 9379-9395.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert